US Stock MarketDetailed Quotes

Silexion Therapeutics (SLXN)

Watchlist
  • 1.070
  • +0.070+7.00%
Close Apr 17 16:00 ET
  • 1.070
  • 0.0000.00%
Post 19:36 ET
4.36MMarket Cap-0.12P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Silexion Therapeutics (SLXN) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-7.47%11.63M
131.89%4.41M
-59.03%3.29M
64.91%2.28M
32.00%1.65M
168.55%12.57M
9.95%1.9M
999.32%8.04M
-2.05%1.39M
54.70%1.25M
Selling and administrative expenses
-33.47%4.48M
-1.25%1.03M
-76.42%1.13M
106.37%1.26M
275.80%1.06M
625.32%6.73M
123.87%1.04M
2,479.03%4.8M
270.91%612K
150.89%281K
-General and administrative expense
-33.47%4.48M
-1.25%1.03M
-76.42%1.13M
106.37%1.26M
275.80%1.06M
625.32%6.73M
123.87%1.04M
2,479.03%4.8M
270.91%612K
150.89%281K
Research and development costs
22.79%7.14M
287.49%3.38M
-32.95%2.16M
32.90%1.02M
-38.61%590K
56.82%5.82M
-30.71%871K
501.31%3.22M
-37.98%766K
41.12%961K
Depreciation amortization depletion
-44.00%14K
125.00%3K
-81.82%4K
-57.14%3K
-50.00%4K
-44.44%25K
-300.00%-12K
120.00%22K
-50.00%7K
-46.67%8K
-Depreciation and amortization
-44.00%14K
125.00%3K
-81.82%4K
-57.14%3K
-50.00%4K
-44.44%25K
-300.00%-12K
120.00%22K
-50.00%7K
-46.67%8K
Operating profit
7.47%-11.63M
-131.89%-4.41M
59.03%-3.29M
-64.91%-2.28M
-32.00%-1.65M
-168.55%-12.57M
-9.95%-1.9M
-999.32%-8.04M
2.05%-1.39M
-54.70%-1.25M
Net non-operating interest income expense
102.66%129K
133.12%313K
101.64%62K
975.00%43K
-46.77%-91K
-3,461.81%-4.84M
-1,343.42%-945K
-125,700.00%-3.77M
-87.88%4K
-263.16%-62K
Non-operating interest income
14,100.00%142K
387.50%69K
--39K
616.67%43K
----
-99.35%1K
-172.73%-24K
--0
-84.62%6K
-51.28%19K
Non-operating interest expense
85.71%13K
200.00%6K
33.33%4K
--0
--9K
16.67%7K
--2K
--3K
-33.33%2K
----
Total other finance cost
----
----
-100.72%-27K
----
1.23%82K
161,066.67%4.84M
1,975.51%919K
8,280.00%3.77M
----
8,000.00%81K
Other net income (expense)
-144.96%-406K
-129.03%-319K
33.33%-32K
-144.34%-259K
105.66%6K
267.53%903K
5,095.45%1.1M
30.43%-48K
78.14%-106K
-386.49%-106K
Gain on sale of security
48.58%-127K
21.57%-40K
33.33%-32K
-45.24%-61K
105.66%6K
45.47%-247K
-176.12%-51K
30.43%-48K
91.38%-42K
-394.44%-106K
Other non- operating income (expenses)
-124.26%-279K
----
----
-209.38%-198K
----
1,437.21%1.15M
359.55%231K
--1.06M
-3,300.00%-64K
----
Income before tax
27.86%-11.91M
-152.69%-4.41M
72.49%-3.26M
-68.12%-2.5M
-22.36%-1.74M
-225.24%-16.51M
-4.30%-1.75M
-1,376.71%-11.86M
20.31%-1.49M
-93.45%-1.42M
Income tax
-70.00%3K
0
0
50.00%3K
-68.75%10K
-83.33%1K
-66.67%2K
-80.00%2K
-50.00%5K
Net income
27.89%-11.91M
-152.55%-4.41M
72.50%-3.26M
-68.10%-2.5M
-21.93%-1.74M
-223.39%-16.52M
-3.99%-1.75M
-1,366.01%-11.86M
20.63%-1.49M
-91.52%-1.42M
Net income continuous Operations
27.89%-11.91M
-152.55%-4.41M
72.50%-3.26M
-68.10%-2.5M
-21.93%-1.74M
-223.39%-16.52M
-3.99%-1.75M
-1,366.01%-11.86M
20.63%-1.49M
-91.52%-1.42M
Minority interest income
0
0
0
0
0
54.22%-76K
0
59.09%-9K
92.38%-17K
-261.29%-50K
Net income attributable to the parent company
27.56%-11.91M
-152.55%-4.41M
72.47%-3.26M
-70.04%-2.5M
-26.37%-1.74M
-232.72%-16.44M
-1.10%-1.75M
-1,405.84%-11.85M
10.95%-1.47M
-77.39%-1.37M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
27.56%-11.91M
-152.55%-4.41M
72.47%-3.26M
-70.04%-2.5M
-26.37%-1.74M
-232.72%-16.44M
-1.10%-1.75M
-1,405.84%-11.85M
10.95%-1.47M
-77.39%-1.37M
Basic earnings per share
97.73%-8.96
90.05%-1.4111
98.95%-2.88
117.72%4.32
82.85%-3.9
-382.54%-394.94
50.47%-14.1748
-2,004.16%-274.25
10.95%-24.3781
-77.39%-22.7386
Diluted earnings per share
97.73%-8.96
90.05%-1.4111
98.95%-2.88
117.72%4.32
82.85%-3.9
-382.54%-394.94
50.47%-14.1748
-2,004.16%-274.25
10.95%-24.3781
-77.39%-22.7386
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -7.47%11.63M131.89%4.41M-59.03%3.29M64.91%2.28M32.00%1.65M168.55%12.57M9.95%1.9M999.32%8.04M-2.05%1.39M54.70%1.25M
Selling and administrative expenses -33.47%4.48M-1.25%1.03M-76.42%1.13M106.37%1.26M275.80%1.06M625.32%6.73M123.87%1.04M2,479.03%4.8M270.91%612K150.89%281K
-General and administrative expense -33.47%4.48M-1.25%1.03M-76.42%1.13M106.37%1.26M275.80%1.06M625.32%6.73M123.87%1.04M2,479.03%4.8M270.91%612K150.89%281K
Research and development costs 22.79%7.14M287.49%3.38M-32.95%2.16M32.90%1.02M-38.61%590K56.82%5.82M-30.71%871K501.31%3.22M-37.98%766K41.12%961K
Depreciation amortization depletion -44.00%14K125.00%3K-81.82%4K-57.14%3K-50.00%4K-44.44%25K-300.00%-12K120.00%22K-50.00%7K-46.67%8K
-Depreciation and amortization -44.00%14K125.00%3K-81.82%4K-57.14%3K-50.00%4K-44.44%25K-300.00%-12K120.00%22K-50.00%7K-46.67%8K
Operating profit 7.47%-11.63M-131.89%-4.41M59.03%-3.29M-64.91%-2.28M-32.00%-1.65M-168.55%-12.57M-9.95%-1.9M-999.32%-8.04M2.05%-1.39M-54.70%-1.25M
Net non-operating interest income expense 102.66%129K133.12%313K101.64%62K975.00%43K-46.77%-91K-3,461.81%-4.84M-1,343.42%-945K-125,700.00%-3.77M-87.88%4K-263.16%-62K
Non-operating interest income 14,100.00%142K387.50%69K--39K616.67%43K-----99.35%1K-172.73%-24K--0-84.62%6K-51.28%19K
Non-operating interest expense 85.71%13K200.00%6K33.33%4K--0--9K16.67%7K--2K--3K-33.33%2K----
Total other finance cost ---------100.72%-27K----1.23%82K161,066.67%4.84M1,975.51%919K8,280.00%3.77M----8,000.00%81K
Other net income (expense) -144.96%-406K-129.03%-319K33.33%-32K-144.34%-259K105.66%6K267.53%903K5,095.45%1.1M30.43%-48K78.14%-106K-386.49%-106K
Gain on sale of security 48.58%-127K21.57%-40K33.33%-32K-45.24%-61K105.66%6K45.47%-247K-176.12%-51K30.43%-48K91.38%-42K-394.44%-106K
Other non- operating income (expenses) -124.26%-279K---------209.38%-198K----1,437.21%1.15M359.55%231K--1.06M-3,300.00%-64K----
Income before tax 27.86%-11.91M-152.69%-4.41M72.49%-3.26M-68.12%-2.5M-22.36%-1.74M-225.24%-16.51M-4.30%-1.75M-1,376.71%-11.86M20.31%-1.49M-93.45%-1.42M
Income tax -70.00%3K0050.00%3K-68.75%10K-83.33%1K-66.67%2K-80.00%2K-50.00%5K
Net income 27.89%-11.91M-152.55%-4.41M72.50%-3.26M-68.10%-2.5M-21.93%-1.74M-223.39%-16.52M-3.99%-1.75M-1,366.01%-11.86M20.63%-1.49M-91.52%-1.42M
Net income continuous Operations 27.89%-11.91M-152.55%-4.41M72.50%-3.26M-68.10%-2.5M-21.93%-1.74M-223.39%-16.52M-3.99%-1.75M-1,366.01%-11.86M20.63%-1.49M-91.52%-1.42M
Minority interest income 0000054.22%-76K059.09%-9K92.38%-17K-261.29%-50K
Net income attributable to the parent company 27.56%-11.91M-152.55%-4.41M72.47%-3.26M-70.04%-2.5M-26.37%-1.74M-232.72%-16.44M-1.10%-1.75M-1,405.84%-11.85M10.95%-1.47M-77.39%-1.37M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 27.56%-11.91M-152.55%-4.41M72.47%-3.26M-70.04%-2.5M-26.37%-1.74M-232.72%-16.44M-1.10%-1.75M-1,405.84%-11.85M10.95%-1.47M-77.39%-1.37M
Basic earnings per share 97.73%-8.9690.05%-1.411198.95%-2.88117.72%4.3282.85%-3.9-382.54%-394.9450.47%-14.1748-2,004.16%-274.2510.95%-24.3781-77.39%-22.7386
Diluted earnings per share 97.73%-8.9690.05%-1.411198.95%-2.88117.72%4.3282.85%-3.9-382.54%-394.9450.47%-14.1748-2,004.16%-274.2510.95%-24.3781-77.39%-22.7386
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -